Correction to: CRISPR-Cas, a robust gene-editing technology in the era of modern cancer immunotherapy
An amendment to this paper has been published and can be accessed via the original article.
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2020-10-01
|
| Series: | Cancer Cell International |
| Online Access: | http://link.springer.com/article/10.1186/s12935-020-01609-w |